Resmed (RMD) Total Current Liabilities (2010 - 2026)
Resmed's (RMD) quarterly Total Current Liabilities came in at $1.4 billion in Q1 2026, up 43.67% YoY from $940.5 million in Q1 2025, and up 8.26% on a QoQ basis from $1.2 billion in Q4 2025.
Resmed (RMD) Total Current Liabilities (2010 - 2026) Analysis & Trends
Resmed (RMD) has 17 years of Total Current Liabilities data on file, last reported at $1.4 billion in Q1 2026.
- Quarterly Total Current Liabilities rose 43.67% year-over-year to $1.4 billion in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.4 billion (up 43.67% YoY) and the FY2025 annual result came in at $1.0 billion, up 11.91% from the prior year.
- Total Current Liabilities climbed to $1.4 billion in Q1 2026, from $1.2 billion in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $1.4 billion in Q1 2026 to a low of $667.3 million in Q1 2022.
- A 5-year average of $887.7 million and a median of $773.0 million in 2024 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities fell 24.4% — and 2025, when it jumped 46.5%.
- Tracing RMD's Total Current Liabilities over 5 years: stood at $732.7 million in 2022, then advanced by 4.28% to $764.1 million in 2023, then gained by 11.5% to $852.0 million in 2024, then soared by 46.5% to $1.2 billion in 2025, then rose by 8.26% to $1.4 billion in 2026.
- The last three Total Current Liabilities figures came in at $1.4 billion (Q1 2026), $1.2 billion (Q4 2025), and $1.3 billion (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Intuitive Surgical | 132.71 Bn | 127.50 Bn | 1.96 Bn | 1.92 Bn |
| 2 | Becton Dickinson | 51.57 Bn | 50.71 Bn | 2.32 Bn | 9.40 Bn |
| 3 | Alcon | 35.52 Bn | 34.17 Bn | 1.68 Bn | 3.17 Bn |
| 4 | Resmed | 33.28 Bn | 31.81 Bn | 861.22 Mn | 1.40 Bn |
| 5 | Medline | 27.86 Bn | 25.18 Bn | 2.22 Bn | 2.71 Bn |
| 6 | West Pharmaceutical Services | 25.15 Bn | 24.71 Bn | 329.20 Mn | 640.50 Mn |
| 7 | Solventum | 15.31 Bn | 14.91 Bn | 1.29 Bn | 3.66 Bn |
| 8 | Cooper Companies | 14.86 Bn | 14.72 Bn | 735.40 Mn | 1.80 Bn |
| 9 | Baxter International | 13.63 Bn | 11.48 Bn | 1.03 Bn | 3.59 Bn |
| 10 | Align Technology | 11.37 Bn | 10.27 Bn | 757.43 Mn | 1.91 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.40 Bn |
| Mar 31, 2026 | 1.35 Bn |
| Dec 31, 2025 | 1.25 Bn |
| Sep 30, 2025 | 1.26 Bn |
| Jun 30, 2025 | 1.02 Bn |
| Mar 31, 2025 | 940.52 Mn |
| Dec 31, 2024 | 851.96 Mn |
| Sep 30, 2024 | 904.08 Mn |
| Jun 30, 2024 | 910.66 Mn |
| Mar 31, 2024 | 773.03 Mn |
| Dec 31, 2023 | 764.07 Mn |
| Sep 30, 2023 | 770.80 Mn |
| Jun 30, 2023 | 758.53 Mn |
| Mar 31, 2023 | 761.69 Mn |
| Dec 31, 2022 | 732.71 Mn |
| Sep 30, 2022 | 692.66 Mn |
| Jun 30, 2022 | 689.30 Mn |
| Mar 31, 2022 | 667.27 Mn |
| Dec 31, 2021 | 621.06 Mn |
| Sep 30, 2021 | 624.16 Mn |